Skip to main content
. 2019 Nov 6;26(5):1578–1588. doi: 10.1038/s41380-019-0578-y

Table 4.

Associations of maternal and neonatal 25OHD and ASD by presence or absence of intellectual disability in the Stockholm Youth Cohort. N of exposed ASD cases in each strata of analysis / odds ratio (95% confidence interval)

Outcome Total sample n = 766 Nordic mothersa n = 573
ASD
 Maternal below median, neonatal below median 131/1.75 (1.08, 2.86) 57/1.94 (1.11, 3.41)
 Maternal below median, neonatal above median 60/1.48 (0.92, 2.40) 51/1.78 (1.04, 3.06)
 Maternal above median, neonatal below median 51/1.17 (0.73, 1.89) 46/1.04 (0.62, 1.75)
 Maternal above median, neonatal above median 98/Ref 93/Ref
ASD without ID
 Maternal below median, neonatal below median 73/2.13 (1.24, 3.70) 46/1.99 (1.09, 3.63)
 Maternal below median, neonatal above median 40/1.50 (0.86, 2.59) 38/1.64 (0.91, 2.96)
 Maternal above median, neonatal below median 39/1.11 (0.65, 1.89) 36/1.02 (0.57, 1.78)
 Maternal above median, neonatal above median 74/Ref 72/Ref
ASD with ID
 Maternal below median, neonatal below median 58/1.24 (0.56, 2.72) 11/2.03 (0.76, 5.40)
 Maternal below median, neonatal above median 20/1.46 (0.68, 3.08) 13/2.40 (0.95, 6.05)
 Maternal above median, neonatal below median 12/1.20 (0.52, 2.65) 10/0.83 (0.32, 2.11)
 Maternal above median, neonatal above median 24/Ref 21/Ref

Median sera 25OHD: 55.1 nmol/L; median neonatal 25OHD: 27.2 nmol/L

Estimates are derived from logistic regression models adjusted for year of birth, sample month, and maternal characteristics: psychiatric disorders, age, body mass index, smoking, nutritional supplement use, and region of origin

aAdjusted for all of above except for maternal region of origin